Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer
- 1 December 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Surgery
- Vol. 176 (6), 502-509
- https://doi.org/10.1016/s0002-9610(98)00253-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.Journal of Clinical Oncology, 1998
- Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.Journal of Clinical Oncology, 1997
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breastCancer, 1994
- Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinomaCancer, 1992
- The Prognostic Significance of Lymph Node Metastases After Preoperative Chemotherapy for Locally Advanced Breast CancerArchives of Surgery, 1989
- Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy with or without RadiationNew England Journal of Medicine, 1985
- Multimodal treatment of locoregionally advanced breast cancerCancer, 1983
- Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancerCancer Chemotherapy and Pharmacology, 1978